Want to join the conversation?
$EW's Surgical Heart Valve Therapy product group sales for 2Q16 slid by 2.6% from last year, or down 3.3% on an underlying basis. Globally, sales were impacted in surgical mitral valves due to a temporary suspension of production, which was partially offset by solid growth in surgical aortic valves.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?